116 related articles for article (PubMed ID: 2805177)
1. Radiosensitizing hypoxic cells with new 3-nitro-1,2,4-triazole derivatives in vitro and in vivo.
Nagao Y; Sano S; Ochiai M; Fuji K; Nishimoto S; Kagiya T; Murayama C; Mori T; Shibamoto Y; Sasai K
Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1951-3. PubMed ID: 2805177
[TBL] [Abstract][Full Text] [Related]
2. 3-Nitro-1,2,4-triazoles as hypoxia-selective agents.
Jenkins TC; Stratford IJ; Stephens MA
Anticancer Drug Des; 1989 Aug; 4(2):145-60. PubMed ID: 2803463
[TBL] [Abstract][Full Text] [Related]
3. Nitrotriazoles bearing sulfur-substituted side chains: preparation and characterization as hypoxic cell radiosensitizers.
Sugita T; Masuoka M; Nishikawa Y; Nishimoto S; Zhou L; Sasai K; Kagiya T
Anticancer Drug Des; 1992 Jun; 7(3):277-84. PubMed ID: 1610484
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization in vitro and in vivo by 3-nitrotriazoles.
Shibamoto Y; Sakano K; Kimura R; Nishidai T; Nishimoto S; Ono K; Kagiya T; Abe M
Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1063-6. PubMed ID: 3744928
[TBL] [Abstract][Full Text] [Related]
5. Metabolic rate modification of nitrotriazole radiosensitizers by sulfur substitution of side chain.
Kagiya VT; Sugita T; Nishimoto S; Masuoka M; Zhou L; Abe M; Shibamoto Y; Sasai K
Int J Radiat Oncol Biol Phys; 1992; 22(3):597-600. PubMed ID: 1735698
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitizers of hypoxic mammalian cells. 1-(Hydroxyaminoalkyl)-substituted nitroimidazoles.
Ahmed I; Stratford IJ; Jenkins TC
Arzneimittelforschung; 1985; 35(12):1763-8. PubMed ID: 4096727
[TBL] [Abstract][Full Text] [Related]
7. Potential radiosensitizing agents. 5. 2-Substituted benzimidazole derivatives.
Gupta RP; Larroquette CA; Agrawal KC
J Med Chem; 1982 Nov; 25(11):1342-6. PubMed ID: 7143372
[TBL] [Abstract][Full Text] [Related]
8. Electron-affinic radiosensitizers possessing NPSH-reactive side chains: cytotoxicity and radiosensitizing activity towards hypoxic EMT6 cells in vitro.
Zhou L; Nishimoto S
Int J Radiat Biol; 1995 Mar; 67(3):335-46. PubMed ID: 7897282
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and tuberculostatic activity of some (4-phenylpiperazin-1-ylmethyl)-1,3,4-oxadiazole and (4-phenylpiperazin-1-ylmethyl)-1,2,4-triazole derivatives.
Foks H; Pancechowska-Ksepko D; Janowiec M; Zwolska Z; Augustynowicz-Kopeć E
Acta Pol Pharm; 2004; 61(6):473-6. PubMed ID: 15794341
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-selective antitumor agents. 8. Bis(nitroimidazolyl)alkanecarboxamides: a new class of hypoxia-selective cytotoxins and hypoxic cell radiosensitisers.
Hay MP; Wilson WR; Moselen JW; Palmer BD; Denny WA
J Med Chem; 1994 Feb; 37(3):381-91. PubMed ID: 8308864
[TBL] [Abstract][Full Text] [Related]
11. Potential Radiosensitizing Agents III: 2-Nitro-4-acetylimidazole analogs.
Sehgal RK; Agrawal KC
J Pharm Sci; 1982 Nov; 71(11):1203-6. PubMed ID: 7175708
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis and radiosensitizing activity of nitro-arylimino-diethyl-sodium thiosulfate and nitro phenylalanine derivatives].
Liu HX; Hu B; Li Z; Mi FS; Shen Y
Yao Xue Xue Bao; 1992; 27(8):632-7. PubMed ID: 1481683
[TBL] [Abstract][Full Text] [Related]
13. TX-1877: design, synthesis, and biological activities as a BRM-functional hypoxic cell radiosensitizer.
Kasai S; Nagasawa H; Kuwasaka H; Oshodani T; Nishioka A; Ogawa Y; Yoshida S; Inayama S; Inomata T; Hori H
Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):799-802. PubMed ID: 9845099
[TBL] [Abstract][Full Text] [Related]
14. Potential radiosensitizing agents. 7. 4(5)-Iodo-5(4)-nitroimidazole derivatives.
Gupta RP; Larroquette CA; Agrawal KC; Grodkowski J; Neta P
J Med Chem; 1985 Aug; 28(8):987-91. PubMed ID: 4020837
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of in vitro antimycobacterial activity of some 5-(5-nitro-2-thienyl)-2-(piperazinyl, piperidinyl and morpholinyl)-1,3,4-thiadiazole derivatives.
Foroumadi A; Soltani F; Rezaee MA; Moshafi MH
Boll Chim Farm; 2003 Nov; 142(9):416-9. PubMed ID: 14971311
[TBL] [Abstract][Full Text] [Related]
16. Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
Bejot R; Kersemans V; Kelly C; Carroll L; King RC; Gouverneur V; Elizarov AM; Ball C; Zhang J; Miraghaie R; Kolb HC; Smart S; Hill S
Nucl Med Biol; 2010 Jul; 37(5):565-75. PubMed ID: 20610161
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of anti-angiogenic hypoxic cell radiosensitizer haloacetylcarbamoyl-2-nitroimidazoles.
Hori H; Jin CZ; Kiyono M; Kasai S; Shimamura M; Inayama S
Bioorg Med Chem; 1997 Mar; 5(3):591-9. PubMed ID: 9113337
[TBL] [Abstract][Full Text] [Related]
18. Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs.
Fielden EM; Adams GE; Cole S; Naylor MA; O'Neill P; Stephens MA; Stratford IJ
Int J Radiat Oncol Biol Phys; 1992; 22(4):707-11. PubMed ID: 1544842
[TBL] [Abstract][Full Text] [Related]
19. Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.
Chapman JD; Reuvers AP; Borsa J; Henderson JS; Migliore RD
Cancer Chemother Rep; 1974; 58(4):559-70. PubMed ID: 4853356
[No Abstract] [Full Text] [Related]
20. 2-Arylidene-4-cyclopentene-1,3-diones designed as non-nitro radiosensitizers and hypoxic cytotoxins.
Hori H; Maezawa H; Iitaka Y; Ohsaka T; Shibata T; Mori T; Inayama S
Jpn J Cancer Res; 1987 Oct; 78(10):1128-33. PubMed ID: 3119546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
